Evaluation of below-the-knee drug-eluting stents with frequency-domain optical coherence tomography: Neointimal hyperplasia and neoatherosclerosis

Journal of Endovascular Therapy

Volumn 20, Issue 1, 2013, Pages 80-93

  Paraskevopoulos, Ioannis ^a   Spiliopoulos, Stavros ^a   Davlouros, Periklis ^a   Karnabatidis, Dimitrios ^a   Katsanos, Konstantinos ^a   Alexopoulos, Dimitrios ^a   Siablis, Dimitrios ^a  

^a UNIVERSITY HOSPITAL OF PATRAS   (Greece)

Author keywords

Atherosclerosis; Below knee arteries; Drug eluting stent; Infrapopliteal arteries; Neointimal hyperplasia; Optical coherence tomography; Peripheral vascular disease; Peroneal artery; Tibial artery; Tibioperoneal artery

Indexed keywords

EVEROLIMUS; RAPAMYCIN;

AGED; ARTERY CALCIFICATION; ARTERY THROMBOSIS; ARTICLE; ATHEROSCLEROSIS; CLINICAL ARTICLE; CONTROLLED STUDY; DRUG ELUTING STENT; FEMALE; FOLLOW UP; FREQUENCY DOMAIN OPTICAL COHERENCE TOMOGRAPHY; HUMAN; HYPERPLASIA; IMAGE ANALYSIS; IN-STENT RESTENOSIS; MALE; NEOINTIMA; NEOVASCULARIZATION (PATHOLOGY); OBSERVATIONAL STUDY; OPTICAL COHERENCE TOMOGRAPHY; PERIPHERAL OCCLUSIVE ARTERY DISEASE; PRIORITY JOURNAL; PROSPECTIVE STUDY; RELAPSE;

AGED; ATHEROSCLEROSIS; DRUG-ELUTING STENTS; FEMALE; HUMANS; HYPERPLASIA; ISCHEMIA; LEG; MALE; NEOINTIMA; POSTOPERATIVE COMPLICATIONS; PROSPECTIVE STUDIES; TOMOGRAPHY, OPTICAL COHERENCE;

EID: 84875444913     PISSN: 15266028     EISSN: 15451550     Source Type: Journal    
DOI: 10.1583/12-4091.1     Document Type: Article

References (32)

1. Karnabatidis D, Spiliopoulos S, Katsanos K, et al. Below-the-knee drug-eluting stents and drug-coated balloons. Expert Rev Med Devices. 2012;9:85-94.
2. Rogers JH, Laird JR. Overview of new technologies for lower extremity revascularization. Circulation. 2007;116:2072-2085. (Pubitemid 350027514)
3. Karnabatidis D, Spiliopoulos S, Diamantopoulos A, et al. Primary everolimus-eluting stenting versus balloon angioplasty with bailout bare metal stenting of long infrapopliteal lesions for treatment of critical limb ischemia. J Endovasc Ther. 2011;18:1-12.
4. Siablis D, Karnabatidis D, Katsanos K, et al. Infrapopliteal application of sirolimus-eluting versus bare metal stents for critical limb ischemia: analysis of long-term angiographic and clinical outcome. J Vasc Interv Radiol. 2009;20:1141-1150.
5. Rastan A, Tepe G, Krankenberg H, et al. Sirolimus-eluting stents vs. bare-metal stents for treatment of focal lesions in infrapopliteal arteries: a double-blind, multi-centre, randomized clinical trial. Eur Heart J. 2011;32:2274-2281.
6. Kang SJ, Mintz GS, Park DW, et al. Tissue characterization of in-stent neointima using intravascular ultrasound radiofrequency data analysis. Am J Cardiol. 2010;106:1561-1565.
7. Park SJ, Kang SJ, Virmani R, et al. In-stent neoatherosclerosis: a final common pathway of late stent failure. J Am Coll Cardiol. 2012;59: 2051-2057.
8. Takano M, Yamamoto M, Inami S, et al. Appearance of lipid-laden intima and neovascularization after implantation of bare-metal stents extended late-phase observation by intracoronary optical coherence tomography. J Am Coll Cardiol. 2009;55:26-32.
9. Bezerra HG, Costa MA, Guagliumi G, et al. Intracoronary optical coherence tomography: a comprehensive review clinical and research applications. JACC Cardiovasc Interv. 2009;2: 1035-1046.
10. Davlouros P, Damelou A, Karantalis V, et al. Evaluation of culprit saphenous vein graft lesions with optical coherence tomography in patients with acute coronary syndromes. JACC Cardiovasc Interv. 2011;4:683-693.
11. Kang SJ, Mintz GS, Akasaka T, et al. Optical coherence tomographic analysis of in-stent neoatherosclerosis after drug-eluting stent implantation. Circulation. 2011;123:2954-2963.
12. Karnabatidis D, Katsanos K, Paraskevopoulos I, et al. Frequency-domain intravascular optical coherence tomography of the femoropopliteal artery. Cardiovasc Intervent Radiol. 2011;34: 1172-1181.
13. Tsantis S, Kagadis GC, Katsanos K, et al. Automatic vessel lumen segmentation and stent strut detection in intravascular optical coherence tomography. Med Phys. 2012;39: 503-513.
14. Setacci C, de Donato G, Setacci F, et al. Safety and feasibility of intravascular optical coherence tomography using a nonocclusive technique to evaluate carotid plaques before and after stent deployment. J Endovasc Ther. 2012; 19:303-11.
15. Meissner OA, Rieber J, Babaryka G, et al. Intravascular optical coherence tomography: differentiation of atherosclerotic plaques and quantification of vessel dimensions in crural arterial specimens [in German]. Rofo. 2006;178: 214-220. (Pubitemid 43232128)
16. Meissner OA, Rieber J, Babaryka G, et al. Intravascular optical coherence tomography: comparison with histopathology in atherosclerotic peripheral artery specimens. J Vasc Interv Radiol. 2006;17:343-349. (Pubitemid 44341454)
17. Yabushita H, Bouma BE, Houser SL, et al. Characterization of human atherosclerosis by optical coherence tomography. Circulation. 2002;106:1640-1645.
18. Rieber J, Meissner O, Babaryka G, et al. Diagnostic accuracy of optical coherence tomography and intravascular ultrasound for the detection and characterization of atherosclerotic plaque composition in ex-vivo coronary specimens: a comparison with histology. Coron Artery Dis. 2006;17:425-430. (Pubitemid 44309782)
19. Teramoto T, Ikeno F, Otake H, et al. Intriguing peri-strut low-intensity area detected by optical coherence tomography after coronary stent deployment. Circ J. 2010;74:1257-1259
20. Kubo T, Imanishi T, Takarada S, et al. Assessment of culprit lesion morphology in acute myocardial infarction: ability of optical coherence tomography compared with intravascular ultrasound and coronary angioscopy. J Am Coll Cardiol. 2007;50:933-939. (Pubitemid 47313602)
21. Kotani J, Awata M, Nanto S, et al. Incomplete neointimal coverage of sirolimus-eluting stents: angioscopic findings. J Am Coll Cardiol. 2006;47:2108-2111.
22. Bosiers M, Scheinert D, Peeters P, et al. Randomized comparison of everolimus-eluting versus bare-metal stents in patients with critical limb ischemia and infrapopliteal arterial occlusive disease. J Vasc Surg. 2012;55:390-398.
23. Katsanos K, Spiliopoulos S, Krokidis M, et al. Does below-the-knee placement of drug-eluting stents improve clinical outcomes? J Cardiovasc Surg (Torino). 2012;53:195-203.
24. Rastan A, Brechtel K, Krankenberg H, et al. Sirolimus-eluting stents for treatment of infra-popliteal arteries reduce clinical event rate compared to bare-metal stents: long-term results from a randomized trial. J Am Coll Cardiol. 2012;60:587-591.
25. Karnabatidis D, Katsanos K, Siablis D. Infrapopliteal stents: overview and unresolved issues. J Endovasc Ther. 2009;16(Suppl I):I153-I162.
26. Nakazawa G, Otsuka F, Nakano M, et al. The pathology of neoatherosclerosis in human coronary implants bare-metal and drug-eluting stents. J Am Coll Cardiol. 2011;57:1314-1322.
27. Hou J, Qi H, Zhang M, et al. Development of lipid-rich plaque inside bare metal stent: possible mechanism of late stent thrombosis? An optical coherence tomography study. Heart. 2010;96:1187-1190.
28. Virmani R, Kolodgie FD, Burke AP, et al. Atherosclerotic plaque progression and vulnerability to rupture: angiogenesis as a source of intraplaque hemorrhage. Arterioscler Thromb Vasc Biol. 2005;25:2054-2061. (Pubitemid 41416300)
29. Kim BK, Kim JS, Shin DH, et al. Optical coherence tomography evaluation of in-stent restenotic lesions with visible microvessels. J Invasive Cardiol. 2012;24:116-120.
30. Norgren L, Hiatt WR, Dormandy JA, et al. InterSociety Consensus for the Management of Peripheral Arterial Disease (TASC II). J Vasc Surg. 2007;45 Suppl S:S5-67.
31. Higo T, Ueda Y, Oyabu J, et al. Atherosclerotic and thrombogenic neointima formed over sirolimus drug-eluting stent: an angioscopic study. JACC Cardiovasc Imaging. 2009;2:616-624.
32. Davlouros PA, Karantalis V, Xanthopoulou I, et al. Mechanisms of non-fatal stent-related myocardial infarction late following coronary stenting with drug-eluting stents and bare metal stents. Insights from optical coherence tomography. Circ J. 2011;75:2789-2797.